Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|June 20, 2006
An update: health economics of managing multiple myelomaK Moeremans, L AnnemansInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trialK Moeremans, L AnnemansRevue Medicale De Bruxelles|April 10, 2009
[Is long-term use of clopidogrel cost-effective in high-risk atherothrombotic patients?]L Annemans, A De WeverTransfusion Medicine (Oxford, England)|February 17, 2006
Assessment of the economic value of the INTERCEPT blood system in BelgiumK Moeremans, H Warie, L AnnemansRevue Medicale De Bruxelles|February 13, 2015
[Illicit drug use among employees in Belgium: an initial estimate of the costs borne by employers]J Tecco, X Bongaerts, L AnnemansValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Early modelling for assessing health and economic outcomes of drug therapyL Annemans, B Genesté, B JolainRevue Medicale De Liege|August 5, 1998
[An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)]X Kurz, L Annemans, A DresseAnti-Cancer Drugs|July 8, 2000
The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysisL Annemans, G Giaccone, A VergnenègrePublic Health|February 29, 2016
The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in BelgiumN Verhaeghe, O De Greve, L AnnemansActa Clinica Belgica|August 24, 2013
Longitudinal economic consequences of colorectal cancer in a university hospital settingM Van Gelder, M Peeters, L AnnemansPageof 8